AIMC Topic: Drug Discovery

Clear Filters Showing 221 to 230 of 1502 articles

Geometry-Augmented Molecular Representation Learning for Property Prediction.

IEEE/ACM transactions on computational biology and bioinformatics
Accurate molecular representation plays a crucial role in expediting the process of drug discovery. Graph neural networks (GNNs) have demonstrated robust capabilities in molecular representation learning, adept at capturing structural and spatial inf...

A deep learning framework combining molecular image and protein structural representations identifies candidate drugs for pain.

Cell reports methods
Artificial intelligence (AI) and deep learning technologies hold promise for identifying effective drugs for human diseases, including pain. Here, we present an interpretable deep-learning-based ligand image- and receptor's three-dimensional (3D)-str...

Traversing chemical space with active deep learning for low-data drug discovery.

Nature computational science
Deep learning is accelerating drug discovery. However, current approaches are often affected by limitations in the available data, in terms of either size or molecular diversity. Active deep learning has high potential for low-data drug discovery, as...

Drug-target interaction prediction with collaborative contrastive learning and adaptive self-paced sampling strategy.

BMC biology
BACKGROUND: Drug-target interaction (DTI) prediction plays a pivotal role in drug discovery and drug repositioning, enabling the identification of potential drug candidates. However, most previous approaches often do not fully utilize the complementa...

Microbe-drug association prediction model based on graph convolution and attention networks.

Scientific reports
The human microbiome plays a key role in drug development and precision medicine, but understanding its complex interactions with drugs remains a challenge. Identifying microbe-drug associations not only enhances our understanding of their mechanisms...

A Practical Method for Predicting Compound Brain Concentration-Time Profiles: Combination of PK Modeling and Machine Learning.

Molecular pharmaceutics
Given the aging populations in advanced countries globally, many pharmaceutical companies have focused on developing central nervous system (CNS) drugs. However, due to the blood-brain barrier, drugs do not easily reach the target area in the brain. ...

Approved drugs successfully repurposed against based on machine learning predictions.

Frontiers in cellular and infection microbiology
Drug repurposing is a promising approach towards the discovery of novel treatments against Neglected Tropical Diseases, such as Leishmaniases, presenting the advantage of reducing both costs and duration of the drug discovery process. In previous wor...

The Development and Application of KinomePro-DL: A Deep Learning Based Online Small Molecule Kinome Selectivity Profiling Prediction Platform.

Journal of chemical information and modeling
Characterizing the kinome selectivity profiles of kinase inhibitors is essential in the early stages of novel small-molecule drug discovery. This characterization is critical for interpreting potential adverse events caused by off-target polypharmaco...

Data-centric challenges with the application and adoption of artificial intelligence for drug discovery.

Expert opinion on drug discovery
INTRODUCTION: Artificial intelligence (AI) is exhibiting tremendous potential to reduce the massive costs and long timescales of drug discovery. There are however important challenges currently limiting the impact and scope of AI models.

Artificial intelligence and psychedelic medicine.

Annals of the New York Academy of Sciences
Artificial intelligence (AI) and psychedelic medicines are among the most high-profile evolving disruptive innovations within mental healthcare in recent years. Although AI and psychedelics may not have historically shared any common ground, there ex...